LMG Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.03M | Buy |
21,722
+59
| +0.3% | +$11K | 0.83% | 41 |
|
2025
Q1 | $4.54M | Sell |
21,663
-78
| -0.4% | -$16.3K | 1.01% | 35 |
|
2024
Q4 | $3.86M | Buy |
21,741
+820
| +4% | +$146K | 0.84% | 41 |
|
2024
Q3 | $4.13M | Buy |
20,921
+403
| +2% | +$79.6K | 0.95% | 38 |
|
2024
Q2 | $3.52M | Buy |
20,518
+1,084
| +6% | +$186K | 0.88% | 37 |
|
2024
Q1 | $3.54M | Buy |
19,434
+1,520
| +8% | +$277K | 0.89% | 37 |
|
2023
Q4 | $2.78M | Buy |
17,914
+2,053
| +13% | +$318K | 0.77% | 39 |
|
2023
Q3 | $2.36M | Buy |
15,861
+8,119
| +105% | +$1.21M | 0.72% | 45 |
|
2023
Q2 | $1.04M | Buy |
7,742
+697
| +10% | +$93.9K | 0.32% | 60 |
|
2023
Q1 | $1.12M | Sell |
7,045
-2,458
| -26% | -$392K | 0.36% | 58 |
|
2022
Q4 | $1.45M | Buy |
+9,503
| New | +$1.45M | 0.48% | 49 |
|